These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure. Missale C, Metra M, Sigala S, Memo M, Dei Cas L, Spano PF. J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S72-6. PubMed ID: 2483443 [Abstract] [Full Text] [Related]
4. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations. Dei Cas L, Metra M, Nodari S, Visioli O. J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436 [Abstract] [Full Text] [Related]
5. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure. Ghirardi P, Brusoni B, Mangiavacchi M, Bianco L, Col J, Metra M, Dei Cas L. Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102 [Abstract] [Full Text] [Related]
6. Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels. Rajfer SI, Rossen JD, Douglas FL, Goldberg LI, Karrison T. Circulation; 1986 Apr; 73(4):740-8. PubMed ID: 3948372 [Abstract] [Full Text] [Related]
9. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure. Lieverse AG, van Veldhuisen DJ, Smit AJ, Zijlstra JG, Meijer S, Reitsma WD, Lie KI, Girbes AR. J Cardiovasc Pharmacol; 1995 Mar; 25(3):361-7. PubMed ID: 7769799 [Abstract] [Full Text] [Related]
10. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, Withagen AJ, Pasteuning WH, Brouwer J, Lie KI. J Am Coll Cardiol; 1993 Nov 15; 22(6):1564-73. PubMed ID: 7901256 [Abstract] [Full Text] [Related]
15. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure. Gavazzi A, Mussini A, Bramucci E. Arzneimittelforschung; 1986 Feb 15; 36(2A):366-70. PubMed ID: 3707652 [Abstract] [Full Text] [Related]
16. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure. Nakano T, Morimoto Y, Kakuta Y, Konishi T, Kodera T, Kanamaru M, Takezawa H. Arzneimittelforschung; 1986 Dec 15; 36(12):1829-34. PubMed ID: 3551968 [Abstract] [Full Text] [Related]
17. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure. Dei Cas L, Metra M, Visioli O. Am J Cardiol; 1992 Sep 01; 70(6):629-34. PubMed ID: 1354938 [Abstract] [Full Text] [Related]
18. Effects of ibopamine on exercise-induced increase in norepinephrine in normal men. Girbes AR, Van Veldhuisen DJ, Grevink RG, Smith AJ, Reitsma WD. J Cardiovasc Pharmacol; 1992 Mar 01; 19(3):371-4. PubMed ID: 1378116 [Abstract] [Full Text] [Related]